Modafinil augmentation for residual symptoms of fatigue in patients with a partial response to antidepressants

Annals of Pharmacotherapy

Volumn 41, Issue 6, 2007, Pages 1005-1012

  Lam, Jenny Y ^a   Freeman, Maisha Kelly ^b   Cates, Marshall E ^b  

^a UAB HEALTH SYSTEM   (United States)

^b SAMFORD UNIVERSITY   (United States)

Author keywords

Antidepressants; Depression; Modafinil

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; MIRTAZAPINE; MODAFINIL; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT;

AGITATION; ANOREXIA; CLINICAL TRIAL; DEPRESSION; DISEASE ASSOCIATION; DIZZINESS; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; HEADACHE; HEART PALPITATION; HUMAN; INSOMNIA; MENTAL CONCENTRATION; MONOTHERAPY; NAUSEA; NERVOUSNESS; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZATION; RATING SCALE; REVIEW; SIDE EFFECT; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA;

ANTIDEPRESSIVE AGENTS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; DEPRESSION; FATIGUE; HUMANS;

EID: 34250185335     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1H526     Document Type: Review

References (24)

1. Menza M, Marin H, Opper RS. Residual symptoms in depression: can treatment be symptom-specific? J Clin Psychiatry 2003;64:516-23.
2. Marin H, Menza MA. The management of fatigue in depressed patients. Essent Pscyhopharmacol 2005;6:185-92.
3. American Psychiatric Association. Treating major depressive disorder. A quick reference guide. www.psych.org/psych_pract/treatg/quick_ref_guide/MDD_QRG. pdf (accessed 2006 Nov 5).
4. Nierenberg A, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-5.
5. Demyttenaere K, De Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol 2005;8:93-105.
6. Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry 2006;67:554-66.
7. Price CS, Taylor FB. A retrospective chart review of the effects of modafinil on depression as monotherapy and as adjunctive therapy. Depress Anxiety 2005;21:149-53.
8. Konuk N, Astoy N, Atik L, Akay O. Open-label study of adjunct modafinil for the treatment of patients with fatigue, sleepiness, and major depression treated with selective serotonin reuptake inhibitors. Adv Ther 2006;23:646-54.
9. Thase ME, Fava M, DeBattista C, Arora S, Hughes RJ. Modafinil augmentation of SSRI therapy in patients with major depressive disorder and excessive sleepiness and fatigue: a 12-week, open-label, extension study. CNS Spectr 2006;11:93-102.
10. Fava M, Thase ME, DeBattista C. A multicenter, placebo-controlled study of modafinil augmentation in partial responders to selective serotonin reuptake inhibitors with persistent fatigue and sleepiness. J Clin Psychiatry 2005;66:85-93.
11. DeBattista C, Lembke A, Solvason HB, Ghebremichael R, Poirier J. A prospective trial of modafinil as an adjunctive treatment of major depression. J Clin Psychopharmacol 2004;24:87-90.
12. Ninan PT, Hassman HA, Glass SJ, McManus FC. Adjunctive modafinil at initiation of treatment with a selective serotonin reuptake inhibitor enhances the degree and onset of therapeutic effects in patients with major depressive disorder and fatigue. J Clin Psychiatry 2004;65:414-20.
13. Schwartz TL, Azhar N, Cole K, et al. An open-label study of adjunctive modafinil in patients with sedation related to serotonergic antidepressant therapy. J Clin Psychiatry 2004;65:1223-7.
14. DeBattista C, Doghramji K, Menza MA, et al. Adjunct modafinil for the short-term treatment of fatigue and sleepiness in patients with major depressive disorder: a preliminary double-blind, placebo-controlled study. J Clin Psychiatry 2003;64:1057-64.
15. Xiong GL, Christopher EJ, Goebel J. Modafinil as an alternative to methylphenidate as augmentation for depression treatment (letter). Psychosomatics 2005;46:578-9.
16. Berigan TR. Augmentation with modafinil to achieve remission in depression: a case report (letter). Prim Care Companion J Clin Psychiatry 2001;3:32.
17. Menza MA, Kaufman KR, Castellanos A. Modafinil augmentation of antidepressant treatment in depression. J Clin Psychiatry 2000;61:378-81.
18. Rasmussen NA, Schroder P, Olsen LR, Brodsgaard M, Uniden M, Bech P. Modafinil augmentation in depressed patients with partial response to antidepressants: a pilot study on self-reported symptoms covered by the major depression inventory (MDI) and the symptom checklist (SCL-92). Nord J Psychiatry 2005;59:173-8.
19. Markovitz PJ, Wagner S. An open-label trial of modafinil augmentation in patients with partial response to antidepressant therapy (letter). J Clin Psychopharmacol 2003;23:207-9.
20. Shen J, Barbera J, Shapiro CM. Distinguishing sleepiness and fatigue: focus on definition and measurement. Sleep Med Rev 2006;10:63-76.
21. Mota DD, Pimenta CA. Self-report instruments for fatigue assessment: a systematic review. Res Theory Nurs Pract 2006;20:49-78.
22. Package insert. Provigil (modafinil). www.provigil.com/pdf_docs/ prescribing_info.pdf?type=Physician&pdf=prescribing_info.pdf (accessed 2006 Jul 21).
23. Clinical Pharmacology Online. www.clinicalpharmacology.com (accessed 2006 Feb 13).
24. O'Brien CP, Dackis CA, Kampman K. Does modafinil produce euphoria (letter)? Am J Psychiatry 2006;163:1109.